Dermatomyositis and polymyositis in total hip arthroplasty

doi:10.5312/wjo.v12.i6.395

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3306)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

217

WORD

139

HTML

1687

Tables (1-3)

199

Sum=2242

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

407

Download

657

Sum=1064

Jun 18, 2021 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Orthop. Jun 18, 2021; 12(6): 395-402
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.395

Table 3 Results of multivariate regression analysis to evaluate the relative risk of complications in patients with idiopathic inflammatory myopathies compared with controls following total hip arthroplasty

Complication		OR (95%CI)	P value
Acute kidney injury	0.034	1.035 (0.817-1.311)	0.778
Cardiac arrest	0.315	1.370 (0.712-2.636)	0.346
Deep vein thrombosis	0.423	1.526 (0.524-4.443)	0.438
Nerve injury	-0.966	0.381 (0.039-3.687)	0.405
Pneumonia¹	0.376	1.456 (1.170-1.812)	0.001
Pulmonary embolism¹	0.378	1.460 (1.026-2.077)	0.035
Urinary tract infection	0.123	1.131 (0.931-1.374)	0.215
Wound disruption	-0.249	0.780 (0.485-1.253)	0.304
Hematoma¹	-0.542	0.582 (0.406-0.833)	0.003
Transfusion	0.060	1.062 (0.861-1.310)	0.573
Capsulitis	0.355	1.426 (0.952-2.137)	0.085
Infection	-0.342	0.71 (0.442-1.139)	0.156

¹Denotes significance, P < 0.05. CI: Confidence interval; OR: Odds ratio.

Citation: Rosas S, Schallmo M, Gowd AK, Akelman MR, Luo TD, Emory CL, Plate JF. Dermatomyositis and polymyositis in total hip arthroplasty. World J Orthop 2021; 12(6): 395-402
URL: https://www.wjgnet.com/2218-5836/full/v12/i6/395.htm
DOI: https://dx.doi.org/10.5312/wjo.v12.i6.395